Study on Big Data in Public Health, Telemedine and Healthcare

The aim of the study on Big Data in Public Health, Telemedicine and Healthcare is to identify applicable examples of the use of Big Data in Health and develop recommendations for their implementation in the European Union. Examples of Big Data in Health were identified by a systematic literature review, after which the added value of twenty selected examples was evaluated. Based on the assessment of the added value and the quality of the evidence, ten priority examples were selected. Furthermore, potential policy actions for the implementation of Big Data in Health were identified in the literature, and a SWOT analysis was conducted to check the feasibility of the proposed actions. Based on this analysis, and with the help of renowned experts, the study team developed ten policy recommendations in the field. These recommendations were validated through public consultations at three relevant conferences in Europe and were again reviewed by the Expert Group.

The recommendations aim to benefit European citizens and patients in terms of strengthening their health and improving the performance of Member State’s health systems. They should be seen as suggestions for the European Union and its Member States on how to utilise the strengths and exploit the opportunities of Big Data for Public Health without threatening privacy or safety of citizens.

Recommendations were developed for ten relevant fields: awareness raising, education and training, data sources, open data and data sharing, applications and purposes, data analysis, governance of data access and use, standards, funding and financial resources, as well as legal aspects and privacy regulation.

Download: Study on Big Data in Public Health, Telemedine and Healthcare (1.655 KB).

Download from eHealthNews.eu: Study on Big Data in Public Health, Telemedine and Healthcare (1.655 KB).

Most Popular Now

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

Model Used to Evaluate Lockdowns was Fla…

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Abbott to Launch the NeuroSphere™ myPath…

Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...